%0 Journal Article
%T Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era
%A Dhiego Chaves de Almeida Bastos
%A Dima Suki
%A Frederick F Lang
%A Ganesh Rao
%A Jeffrey S Weinberg
%A Marcos Vinicius Calfat Maldaun
%A Paul D Brown
%A Raymond Sawaya
%A Sujit S Prabhu
%J Archive of "Neuro-Oncology Practice".
%D 2018
%R 10.1093/nop/npx033
%X There is recognition that breast cancer is a collection of heterogeneous diseases divided in subtypes based on combined molecular features such as hormonal receptors (HR) and human epidermal growth factor receptor 2 (HER2) status. We aimed to study clinical differences among biological subtypes in brain metastasis from breast cancer after targeted therapy introduction
%K brain metastasis
%K breast cancer
%K HER2
%K hormonal receptors
%K molecular subtypes
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655427/